Found: 24
Select item for more details and to access through your institution.
A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment Response.
- Published in:
- Primary Care Companion for CNS Disorders (2155-7772), 2020, v. 22, n. 6, p. 1, doi. 10.4088/pcc.20m02681
- By:
- Publication type:
- Article
Community-level electronic prescribing and adverse drug event hospitalizations among older adults.
- Published in:
- Health Informatics Journal, 2019, v. 25, n. 3, p. 661, doi. 10.1177/1460458217720396
- By:
- Publication type:
- Article
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 2073, doi. 10.2147/PPA.S417180
- By:
- Publication type:
- Article
Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes.
- Published in:
- Neuropsychiatric Disease & Treatment, 2022, v. 18, p. 1057, doi. 10.2147/NDT.S358392
- By:
- Publication type:
- Article
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions ( SONAR).
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 6, p. 896, doi. 10.1111/bjh.12303
- By:
- Publication type:
- Article
Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database.
- Published in:
- BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-04683-2
- By:
- Publication type:
- Article
Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033029
- By:
- Publication type:
- Article
Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Flexible, Computationally Efficient Method for Fitting the Proportional Hazards Model to Interval-Censored Data.
- Published in:
- Biometrics, 2016, v. 72, n. 1, p. 222, doi. 10.1111/biom.12389
- By:
- Publication type:
- Article
Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye's Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR).
- Published in:
- JGIM: Journal of General Internal Medicine, 2012, v. 27, n. 12, p. 1697, doi. 10.1007/s11606-012-2098-1
- By:
- Publication type:
- Article
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1541, doi. 10.1002/cam4.1098
- By:
- Publication type:
- Article
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 271, doi. 10.1007/s40801-023-00356-4
- By:
- Publication type:
- Article
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease.
- Published in:
- Clinical Kidney Journal, 2012, v. 5, n. 1, p. 82, doi. 10.1093/ckj/sfr172
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. e301, doi. 10.1016/j.clml.2024.05.009
- By:
- Publication type:
- Article
Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United States.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 12, p. 1322, doi. 10.1002/phar.1298
- By:
- Publication type:
- Article
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2011, v. 20, n. 7, p. 772, doi. 10.1002/pds.2155
- By:
- Publication type:
- Article
Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1408892
- By:
- Publication type:
- Article
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1405452
- By:
- Publication type:
- Article
Do radiation oncologists and urologists endorse decision aids for active surveillance of low‐risk prostate cancer: Results from a national survey.
- Published in:
- European Journal of Cancer Care, 2021, v. 30, n. 1, p. 1, doi. 10.1111/ecc.13301
- By:
- Publication type:
- Article
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2468, doi. 10.1007/s12325-021-01970-w
- By:
- Publication type:
- Article
A Feasibility Study: Testing Whether a Sleep Application Providing Objective Sleep Data to Physicians Improves Patient–Physician Communication Regarding Sleep Experiences, Habits, and Behaviors.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1612, doi. 10.1007/s12325-021-02013-0
- By:
- Publication type:
- Article
Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 10, p. 5221, doi. 10.1007/s12325-021-01891-8
- By:
- Publication type:
- Article